RECURRENT BRAIN NEOPLASM
Clinical trials for RECURRENT BRAIN NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new RECURRENT BRAIN NEOPLASM trials appear
Sign up with your email to follow new studies for RECURRENT BRAIN NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental drug shows promise for kids with aggressive brain cancers
Disease control OngoingThis study tests a drug called pembrolizumab in children whose brain tumors have come back or not responded to treatment. The drug helps the body's immune system fight cancer cells. The goal is to find the safest dose and see if it can shrink tumors in children with several types…
Matched conditions: RECURRENT BRAIN NEOPLASM
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 07:23 UTC
-
New drug cocktail targets Hard-to-Treat cancers in kids and young adults
Disease control OngoingThis early-phase trial tests a combination of three drugs (dasatinib, temsirolimus, and cyclophosphamide) in children and young adults (ages 1 to 21) with advanced solid tumors that have come back or not responded to standard treatment. The main goals are to find the safest dose …
Matched conditions: RECURRENT BRAIN NEOPLASM
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
Second chance: new radiation plan aims to shrink recurrent brain tumors with fewer side effects
Symptom relief OngoingThis study tests the safety and best dose of a second round of radiation for people whose brain tumors returned after earlier radiation. Forty adults who had one prior brain radiation course at least six months ago will receive targeted reirradiation. The main goal is to see how …
Matched conditions: RECURRENT BRAIN NEOPLASM
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated May 26, 2026 07:33 UTC